A New Risk Score Model to Predict the Presence of Significant Coronary Artery Disease in Renal Transplant Candidates
Overview
Authors
Affiliations
Background: Renal transplant candidates are at high risk of coronary artery disease (CAD). We sought to develop a new risk score model to determine the pre-test probability of the occurrence of significant CAD in renal transplant candidates.
Methods: A total of 1,060 renal transplant candidates underwent a comprehensive cardiovascular risk evaluation. Patients considered at high risk of CAD (age ≥50 years, with either diabetes mellitus (DM) or cardiovascular disease (CVD)), or having noninvasive testing suggestive of CAD were referred for coronary angiography (n = 524). Significant CAD was defined by the presence of luminal stenosis ≥70%. A binary logistic regression model was built, and the resulting logistic regression coefficient B for each variable was multiplied by 10 and rounded to the next whole number. For each patient, a corresponding risk score was calculated and the receiver operating characteristic (ROC) curve was constructed.
Results: The final equation for the model was risk score = (age × 0.4) + (DM × 9) + (CVD × 14) and for the probability of CAD (%) = (risk score × 2) - 23. The corresponding ROC for the accuracy of the diagnosis of CAD was 0.75 (P <0.0001) in the developmental model.
Conclusions: We developed a simple clinical risk score to determine the pre-test probability of significant CAD in renal transplant candidates. This model may help those directly involved in the care of patients with end-stage renal disease being considered for transplantation in an attempt to reduce the rate of cardiovascular events that presently hampers the long-term prognosis of such patients.
Dos Santos D, Gowdak L, David-Neto E, Nataniel F, De Lima J, Bortolotto L J Clin Med. 2023; 12(18).
PMID: 37762822 PMC: 10531783. DOI: 10.3390/jcm12185882.
Cardiac risk assessment for end-stage renal disease patients on the renal transplant waiting list.
Tabriziani H, Baron P, Abudayyeh I, Lipkowitz M Clin Kidney J. 2019; 12(4):576-585.
PMID: 31384451 PMC: 6671484. DOI: 10.1093/ckj/sfz039.
3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.
Gualandro D, Yu P, Caramelli B, Marques A, Calderaro D, Fornari L Arq Bras Cardiol. 2017; 109(3 Supl 1):1-104.
PMID: 29044300 PMC: 5629911. DOI: 10.5935/abc.20170140.
A clinical-genetic approach to assessing cardiovascular risk in patients with CKD.
Rodrigo E, Pich S, Subirana I, Fernandez-Fresnedo G, Barreda P, Ferrer-Costa C Clin Kidney J. 2017; 10(5):672-678.
PMID: 28979779 PMC: 5622901. DOI: 10.1093/ckj/sfx039.
Faludi A, Izar M, Kerr Saraiva J, Chacra A, Bianco H, Afiune Neto A Arq Bras Cardiol. 2017; 109(2 Supl 1):1-76.
PMID: 28813069 DOI: 10.5935/abc.20170121.